COMMUNIQUÉS West-GlobeNewswire

CV Sciences, Inc. Named One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™
14/11/2017
LAS VEGAS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of hemp-derived phytocannabinoids including CBD oil and developer of specialty pharmaceutical [...]
Sun BioPharma Files Form 10-Q for Third Quarter 2017 and Provides Business Update
14/11/2017
Enrollment Completed in Phase 1a Safety Trial Study Design Finalized for Front-Line Combination Study with Gemcitabine and Nab-Paclitaxel MINNEAPOLIS, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (OTCQB:SNBP), [...]
Mustang Bio Announces Appointment of Brian Achenbach as Vice President of Finance and Corporate Controller
14/11/2017
NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech, Inc. (NASDAQ: FBIO ) company focused on the development of novel immunotherapies based on proprietary [...]
Alpha II Announces Launch of Easy Coder Web-based Application
14/11/2017
TALLAHASSEE, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of software-as-a-service (SaaS) solutions that support healthcare reimbursement, today announced the transition of CodingSystem to [...]
Representatives of Fulgent Genetics to Participate in the Piper Jaffray 29th Annual Healthcare Conference
14/11/2017
TEMPLE CITY, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT ) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming Hsieh and its Chief [...]
Mustang Bio Reports Third Quarter 2017 Financial Results and Recent Corporate Highlights
14/11/2017
NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO ), a Fortress Biotech (NASDAQ: FBIO ) Company focused on the development of novel immunotherapies based on proprietary chimeric [...]
Celsion Corporation Reports Third Quarter 2017 Financial Results and Provides Business Update
14/11/2017
Recent Minimally Dilutive Financings Substantially Strengthen Balance Sheet and Provide Runway to Significant Clinical Milestones for ThermoDox ® and GEN-1 Clinical Programs Company to Hold Conference Call on Tuesday, [...]
Rhythm Pharmaceuticals Reports Third Quarter 2017 Financial Results
14/11/2017
- Successfully Completed Upsized Initial Public Offering Raising $137.8 Million in Gross Proceeds - - Presented Preliminary Data from Phase 2 Clinical Trial of Setmelanotide in Bardet-Biedl Syndrome (BBS) at ObesityWeek [...]
RavenQuest Announces Formal Agreement With Fort McMurray #468 First Nation
14/11/2017
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has entered into an agreement with Fort McMurray #468 First [...]
Albireo Reports Third Quarter 2017 Financial Results
14/11/2017
— Executing towards planned A4250 Phase 3 PFIC trial — — Decision on potential approval of elobixibat in Japan expected in the first half of 2018 — BOSTON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ [...]
Gallup and Sharecare Release New Research on the Cost of Diabetes to U.S. Communities and Employers
14/11/2017
WASHINGTON and ATLANTA, Nov. 14, 2017 (GLOBE NEWSWIRE) -- World-leading analytics and advice firm, Gallup, and Sharecare, the digital health company helping people manage all their health in one place, have released new [...]
Cannabix Technologies makes “50 B.C. Innovations to Watch List” with Marijuana Breathalyzer, Added to CSE25 Index
14/11/2017
VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”), developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]
Mateon Provides Corporate Update and Reports Third Quarter 2017 Financial Results
14/11/2017
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year
14/11/2017
DELRAY BEACH, Fla., Nov. 14, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today its financial results for the quarter ended [...]
EyeGate Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
14/11/2017
WALTHAM, Mass., Nov. 14, 2017 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies [...]
Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR-T Therapies at Precision: Blood Cancer Summit
14/11/2017
SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, will participate [...]
Actinium Pharmaceuticals Launches the AWE Program aka Actinium Warhead Enabling Program to Enable Collaborations Based on Its Actinium-225 Technology Platform
14/11/2017
- AWE Program launched post successful demonstration of Actinium’s “Biobetter” capabilities as evidenced by superior experimental results with actinium-225 labeled daratumumab when compared to unlabeled daratumumab, a [...]
Former General Mills Executive Joins Canadian Startup as Advisor
14/11/2017
PETERBOROUGH, Ontario, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Noblegen Inc. (“Noblegen”) — announces the appointment of distinguished industry veteran, Jim Kirkwood, as an official advisor to the Corporation. Kirkwood is a [...]
Intra-Cellular Therapies Presents Data on Mechanism of Action of Lumateperone and ITI-214 at the 2017 Society for Neuroscience (SfN) Annual Meeting
14/11/2017
NEW YORK, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Pages